nodes	percent_of_prediction	percent_of_DWPC	metapath
Sufentanil—OPRD1—coronary artery disease	0.526	1	CbGaD
Sufentanil—CYP3A4—Ticagrelor—coronary artery disease	0.0368	0.146	CbGbCtD
Sufentanil—CYP3A4—Fenofibrate—coronary artery disease	0.0328	0.13	CbGbCtD
Sufentanil—CYP3A4—Gemfibrozil—coronary artery disease	0.0262	0.104	CbGbCtD
Sufentanil—CYP3A4—Clopidogrel—coronary artery disease	0.0227	0.0904	CbGbCtD
Sufentanil—CYP3A4—Eplerenone—coronary artery disease	0.0211	0.0841	CbGbCtD
Sufentanil—CYP3A4—Enalapril—coronary artery disease	0.0188	0.0749	CbGbCtD
Sufentanil—CYP3A4—Ezetimibe—coronary artery disease	0.0147	0.0583	CbGbCtD
Sufentanil—CYP3A4—Rosuvastatin—coronary artery disease	0.0147	0.0583	CbGbCtD
Sufentanil—CYP3A4—Simvastatin—coronary artery disease	0.0136	0.0542	CbGbCtD
Sufentanil—CYP3A4—Pravastatin—coronary artery disease	0.0133	0.053	CbGbCtD
Sufentanil—CYP3A4—Lovastatin—coronary artery disease	0.0133	0.053	CbGbCtD
Sufentanil—CYP3A4—Atorvastatin—coronary artery disease	0.0121	0.0483	CbGbCtD
Sufentanil—CYP3A4—Losartan—coronary artery disease	0.0111	0.0442	CbGbCtD
Sufentanil—Remifentanil—OPRD1—coronary artery disease	0.00185	0.672	CrCbGaD
Sufentanil—Fentanyl—OPRD1—coronary artery disease	0.000562	0.204	CrCbGaD
Sufentanil—Alfentanil—ALB—coronary artery disease	0.00034	0.124	CrCbGaD
Sufentanil—Feeling abnormal—Eplerenone—coronary artery disease	0.000285	0.00223	CcSEcCtD
Sufentanil—Confusional state—Captopril—coronary artery disease	0.000285	0.00223	CcSEcCtD
Sufentanil—Body temperature increased—Lovastatin—coronary artery disease	0.000285	0.00222	CcSEcCtD
Sufentanil—Tachycardia—Telmisartan—coronary artery disease	0.000284	0.00222	CcSEcCtD
Sufentanil—Somnolence—Valsartan—coronary artery disease	0.000283	0.00221	CcSEcCtD
Sufentanil—Anaphylactic shock—Captopril—coronary artery disease	0.000283	0.00221	CcSEcCtD
Sufentanil—Dizziness—Rosuvastatin—coronary artery disease	0.000281	0.0022	CcSEcCtD
Sufentanil—Nausea—Ticagrelor—coronary artery disease	0.000281	0.00219	CcSEcCtD
Sufentanil—Body temperature increased—Ezetimibe—coronary artery disease	0.000279	0.00218	CcSEcCtD
Sufentanil—Urinary tract disorder—Lisinopril—coronary artery disease	0.000278	0.00217	CcSEcCtD
Sufentanil—Feeling abnormal—Simvastatin—coronary artery disease	0.000278	0.00217	CcSEcCtD
Sufentanil—Arrhythmia—Ramipril—coronary artery disease	0.000278	0.00217	CcSEcCtD
Sufentanil—Confusional state—Perindopril—coronary artery disease	0.000277	0.00216	CcSEcCtD
Sufentanil—Hypotension—Trandolapril—coronary artery disease	0.000277	0.00216	CcSEcCtD
Sufentanil—Urethral disorder—Lisinopril—coronary artery disease	0.000276	0.00216	CcSEcCtD
Sufentanil—Tachycardia—Captopril—coronary artery disease	0.000276	0.00215	CcSEcCtD
Sufentanil—Hypotension—Enalapril—coronary artery disease	0.000275	0.00215	CcSEcCtD
Sufentanil—Somnolence—Niacin—coronary artery disease	0.000275	0.00215	CcSEcCtD
Sufentanil—Anaphylactic shock—Perindopril—coronary artery disease	0.000274	0.00214	CcSEcCtD
Sufentanil—Body temperature increased—Eplerenone—coronary artery disease	0.000273	0.00214	CcSEcCtD
Sufentanil—Dizziness—Acetylsalicylic acid—coronary artery disease	0.000273	0.00213	CcSEcCtD
Sufentanil—Hypersensitivity—Fenofibrate—coronary artery disease	0.000272	0.00212	CcSEcCtD
Sufentanil—Hypotension—Telmisartan—coronary artery disease	0.000272	0.00212	CcSEcCtD
Sufentanil—Arrhythmia—Timolol—coronary artery disease	0.000271	0.00212	CcSEcCtD
Sufentanil—Erythema—Ramipril—coronary artery disease	0.00027	0.00211	CcSEcCtD
Sufentanil—Confusional state—Furosemide—coronary artery disease	0.000269	0.0021	CcSEcCtD
Sufentanil—Rash—Rosuvastatin—coronary artery disease	0.000268	0.00209	CcSEcCtD
Sufentanil—Tachycardia—Perindopril—coronary artery disease	0.000268	0.00209	CcSEcCtD
Sufentanil—Dermatitis—Rosuvastatin—coronary artery disease	0.000268	0.00209	CcSEcCtD
Sufentanil—Hypersensitivity—Clopidogrel—coronary artery disease	0.000267	0.00209	CcSEcCtD
Sufentanil—Anaphylactic shock—Furosemide—coronary artery disease	0.000267	0.00208	CcSEcCtD
Sufentanil—Body temperature increased—Simvastatin—coronary artery disease	0.000266	0.00208	CcSEcCtD
Sufentanil—Headache—Rosuvastatin—coronary artery disease	0.000266	0.00208	CcSEcCtD
Sufentanil—Hypersensitivity—Lovastatin—coronary artery disease	0.000266	0.00207	CcSEcCtD
Sufentanil—Erythema—Timolol—coronary artery disease	0.000264	0.00206	CcSEcCtD
Sufentanil—Hypotension—Captopril—coronary artery disease	0.000264	0.00206	CcSEcCtD
Sufentanil—Somnolence—Trandolapril—coronary artery disease	0.000263	0.00205	CcSEcCtD
Sufentanil—Vomiting—Acetylsalicylic acid—coronary artery disease	0.000263	0.00205	CcSEcCtD
Sufentanil—Somnolence—Enalapril—coronary artery disease	0.000262	0.00205	CcSEcCtD
Sufentanil—Pruritus—Fenofibrate—coronary artery disease	0.000261	0.00204	CcSEcCtD
Sufentanil—Feeling abnormal—Olmesartan—coronary artery disease	0.000261	0.00204	CcSEcCtD
Sufentanil—Rash—Acetylsalicylic acid—coronary artery disease	0.00026	0.00203	CcSEcCtD
Sufentanil—Hypersensitivity—Ezetimibe—coronary artery disease	0.00026	0.00203	CcSEcCtD
Sufentanil—Dermatitis—Acetylsalicylic acid—coronary artery disease	0.00026	0.00203	CcSEcCtD
Sufentanil—Confusional state—Losartan—coronary artery disease	0.00026	0.00203	CcSEcCtD
Sufentanil—Somnolence—Telmisartan—coronary artery disease	0.000258	0.00202	CcSEcCtD
Sufentanil—Anaphylactic shock—Losartan—coronary artery disease	0.000257	0.00201	CcSEcCtD
Sufentanil—Pruritus—Clopidogrel—coronary artery disease	0.000257	0.002	CcSEcCtD
Sufentanil—Hypotension—Perindopril—coronary artery disease	0.000256	0.002	CcSEcCtD
Sufentanil—Pruritus—Lovastatin—coronary artery disease	0.000255	0.00199	CcSEcCtD
Sufentanil—Chills—Lisinopril—coronary artery disease	0.000253	0.00197	CcSEcCtD
Sufentanil—Nausea—Rosuvastatin—coronary artery disease	0.000253	0.00197	CcSEcCtD
Sufentanil—Arrhythmia—Lisinopril—coronary artery disease	0.000252	0.00197	CcSEcCtD
Sufentanil—Somnolence—Captopril—coronary artery disease	0.000251	0.00196	CcSEcCtD
Sufentanil—Tachycardia—Losartan—coronary artery disease	0.000251	0.00196	CcSEcCtD
Sufentanil—Feeling abnormal—Pravastatin—coronary artery disease	0.000251	0.00196	CcSEcCtD
Sufentanil—Body temperature increased—Olmesartan—coronary artery disease	0.00025	0.00196	CcSEcCtD
Sufentanil—Pruritus—Ezetimibe—coronary artery disease	0.00025	0.00195	CcSEcCtD
Sufentanil—Hypotension—Furosemide—coronary artery disease	0.000249	0.00195	CcSEcCtD
Sufentanil—Hypersensitivity—Simvastatin—coronary artery disease	0.000248	0.00194	CcSEcCtD
Sufentanil—Nausea—Acetylsalicylic acid—coronary artery disease	0.000245	0.00192	CcSEcCtD
Sufentanil—Erythema—Lisinopril—coronary artery disease	0.000245	0.00192	CcSEcCtD
Sufentanil—Pruritus—Eplerenone—coronary artery disease	0.000245	0.00191	CcSEcCtD
Sufentanil—Body temperature increased—Niacin—coronary artery disease	0.000245	0.00191	CcSEcCtD
Sufentanil—Dizziness—Fenofibrate—coronary artery disease	0.000244	0.00191	CcSEcCtD
Sufentanil—Somnolence—Perindopril—coronary artery disease	0.000244	0.00191	CcSEcCtD
Sufentanil—Feeling abnormal—Trandolapril—coronary artery disease	0.000244	0.0019	CcSEcCtD
Sufentanil—Feeling abnormal—Enalapril—coronary artery disease	0.000243	0.0019	CcSEcCtD
Sufentanil—Body temperature increased—Pravastatin—coronary artery disease	0.000241	0.00188	CcSEcCtD
Sufentanil—Hypotension—Losartan—coronary artery disease	0.000241	0.00188	CcSEcCtD
Sufentanil—Dizziness—Clopidogrel—coronary artery disease	0.00024	0.00187	CcSEcCtD
Sufentanil—Feeling abnormal—Telmisartan—coronary artery disease	0.00024	0.00187	CcSEcCtD
Sufentanil—Pruritus—Simvastatin—coronary artery disease	0.000238	0.00186	CcSEcCtD
Sufentanil—Dizziness—Lovastatin—coronary artery disease	0.000238	0.00186	CcSEcCtD
Sufentanil—Somnolence—Furosemide—coronary artery disease	0.000237	0.00185	CcSEcCtD
Sufentanil—Vomiting—Fenofibrate—coronary artery disease	0.000235	0.00183	CcSEcCtD
Sufentanil—Hypersensitivity—Valsartan—coronary artery disease	0.000235	0.00183	CcSEcCtD
Sufentanil—Body temperature increased—Trandolapril—coronary artery disease	0.000234	0.00183	CcSEcCtD
Sufentanil—Dizziness—Ezetimibe—coronary artery disease	0.000234	0.00182	CcSEcCtD
Sufentanil—Body temperature increased—Enalapril—coronary artery disease	0.000233	0.00182	CcSEcCtD
Sufentanil—Feeling abnormal—Captopril—coronary artery disease	0.000233	0.00182	CcSEcCtD
Sufentanil—Rash—Fenofibrate—coronary artery disease	0.000233	0.00182	CcSEcCtD
Sufentanil—Dermatitis—Fenofibrate—coronary artery disease	0.000232	0.00182	CcSEcCtD
Sufentanil—Headache—Fenofibrate—coronary artery disease	0.000231	0.00181	CcSEcCtD
Sufentanil—Vomiting—Clopidogrel—coronary artery disease	0.000231	0.0018	CcSEcCtD
Sufentanil—Body temperature increased—Telmisartan—coronary artery disease	0.00023	0.00179	CcSEcCtD
Sufentanil—Vomiting—Lovastatin—coronary artery disease	0.000229	0.00179	CcSEcCtD
Sufentanil—Somnolence—Losartan—coronary artery disease	0.000229	0.00179	CcSEcCtD
Sufentanil—Dizziness—Eplerenone—coronary artery disease	0.000229	0.00179	CcSEcCtD
Sufentanil—Rash—Clopidogrel—coronary artery disease	0.000229	0.00179	CcSEcCtD
Sufentanil—Dermatitis—Clopidogrel—coronary artery disease	0.000229	0.00178	CcSEcCtD
Sufentanil—Hypertension—Timolol—coronary artery disease	0.000228	0.00178	CcSEcCtD
Sufentanil—Hypersensitivity—Niacin—coronary artery disease	0.000228	0.00178	CcSEcCtD
Sufentanil—Headache—Clopidogrel—coronary artery disease	0.000227	0.00177	CcSEcCtD
Sufentanil—Rash—Lovastatin—coronary artery disease	0.000227	0.00177	CcSEcCtD
Sufentanil—Dermatitis—Lovastatin—coronary artery disease	0.000227	0.00177	CcSEcCtD
Sufentanil—Feeling abnormal—Perindopril—coronary artery disease	0.000226	0.00177	CcSEcCtD
Sufentanil—Headache—Lovastatin—coronary artery disease	0.000226	0.00176	CcSEcCtD
Sufentanil—Pruritus—Valsartan—coronary artery disease	0.000225	0.00176	CcSEcCtD
Sufentanil—Vomiting—Ezetimibe—coronary artery disease	0.000225	0.00175	CcSEcCtD
Sufentanil—Hypersensitivity—Pravastatin—coronary artery disease	0.000225	0.00175	CcSEcCtD
Sufentanil—Pruritus—Olmesartan—coronary artery disease	0.000224	0.00175	CcSEcCtD
Sufentanil—Body temperature increased—Captopril—coronary artery disease	0.000223	0.00174	CcSEcCtD
Sufentanil—Dizziness—Simvastatin—coronary artery disease	0.000223	0.00174	CcSEcCtD
Sufentanil—Rash—Ezetimibe—coronary artery disease	0.000223	0.00174	CcSEcCtD
Sufentanil—Dermatitis—Ezetimibe—coronary artery disease	0.000223	0.00174	CcSEcCtD
Sufentanil—Confusional state—Ramipril—coronary artery disease	0.000223	0.00174	CcSEcCtD
Sufentanil—Headache—Ezetimibe—coronary artery disease	0.000221	0.00173	CcSEcCtD
Sufentanil—Anaphylactic shock—Ramipril—coronary artery disease	0.000221	0.00172	CcSEcCtD
Sufentanil—Vomiting—Eplerenone—coronary artery disease	0.00022	0.00172	CcSEcCtD
Sufentanil—Feeling abnormal—Furosemide—coronary artery disease	0.00022	0.00172	CcSEcCtD
Sufentanil—Nausea—Fenofibrate—coronary artery disease	0.000219	0.00171	CcSEcCtD
Sufentanil—Pruritus—Niacin—coronary artery disease	0.000219	0.00171	CcSEcCtD
Sufentanil—Rash—Eplerenone—coronary artery disease	0.000218	0.0017	CcSEcCtD
Sufentanil—Hypersensitivity—Trandolapril—coronary artery disease	0.000218	0.0017	CcSEcCtD
Sufentanil—Dermatitis—Eplerenone—coronary artery disease	0.000218	0.0017	CcSEcCtD
Sufentanil—Confusional state—Timolol—coronary artery disease	0.000218	0.0017	CcSEcCtD
Sufentanil—Hypersensitivity—Enalapril—coronary artery disease	0.000217	0.0017	CcSEcCtD
Sufentanil—Body temperature increased—Perindopril—coronary artery disease	0.000217	0.00169	CcSEcCtD
Sufentanil—Headache—Eplerenone—coronary artery disease	0.000217	0.00169	CcSEcCtD
Sufentanil—Anaphylactic shock—Timolol—coronary artery disease	0.000216	0.00169	CcSEcCtD
Sufentanil—Pruritus—Pravastatin—coronary artery disease	0.000216	0.00168	CcSEcCtD
Sufentanil—Nausea—Clopidogrel—coronary artery disease	0.000215	0.00168	CcSEcCtD
Sufentanil—Tachycardia—Ramipril—coronary artery disease	0.000215	0.00168	CcSEcCtD
Sufentanil—Vomiting—Simvastatin—coronary artery disease	0.000214	0.00167	CcSEcCtD
Sufentanil—Hypersensitivity—Telmisartan—coronary artery disease	0.000214	0.00167	CcSEcCtD
Sufentanil—Nausea—Lovastatin—coronary artery disease	0.000214	0.00167	CcSEcCtD
Sufentanil—Rash—Simvastatin—coronary artery disease	0.000213	0.00166	CcSEcCtD
Sufentanil—Dermatitis—Simvastatin—coronary artery disease	0.000212	0.00166	CcSEcCtD
Sufentanil—Feeling abnormal—Losartan—coronary artery disease	0.000212	0.00166	CcSEcCtD
Sufentanil—Headache—Simvastatin—coronary artery disease	0.000211	0.00165	CcSEcCtD
Sufentanil—Body temperature increased—Furosemide—coronary artery disease	0.000211	0.00165	CcSEcCtD
Sufentanil—Dizziness—Valsartan—coronary artery disease	0.000211	0.00164	CcSEcCtD
Sufentanil—Nausea—Ezetimibe—coronary artery disease	0.00021	0.00164	CcSEcCtD
Sufentanil—Dizziness—Olmesartan—coronary artery disease	0.000209	0.00164	CcSEcCtD
Sufentanil—Pruritus—Trandolapril—coronary artery disease	0.000209	0.00163	CcSEcCtD
Sufentanil—Pruritus—Enalapril—coronary artery disease	0.000209	0.00163	CcSEcCtD
Sufentanil—Hypotension—Ramipril—coronary artery disease	0.000206	0.00161	CcSEcCtD
Sufentanil—Pruritus—Telmisartan—coronary artery disease	0.000206	0.00161	CcSEcCtD
Sufentanil—Nausea—Eplerenone—coronary artery disease	0.000205	0.0016	CcSEcCtD
Sufentanil—Dizziness—Niacin—coronary artery disease	0.000205	0.0016	CcSEcCtD
Sufentanil—Body temperature increased—Losartan—coronary artery disease	0.000204	0.00159	CcSEcCtD
Sufentanil—Vomiting—Valsartan—coronary artery disease	0.000202	0.00158	CcSEcCtD
Sufentanil—Confusional state—Lisinopril—coronary artery disease	0.000202	0.00158	CcSEcCtD
Sufentanil—Hypotension—Timolol—coronary artery disease	0.000202	0.00157	CcSEcCtD
Sufentanil—Dizziness—Pravastatin—coronary artery disease	0.000202	0.00157	CcSEcCtD
Sufentanil—Vomiting—Olmesartan—coronary artery disease	0.000201	0.00157	CcSEcCtD
Sufentanil—Rash—Valsartan—coronary artery disease	0.000201	0.00157	CcSEcCtD
Sufentanil—Dermatitis—Valsartan—coronary artery disease	0.000201	0.00157	CcSEcCtD
Sufentanil—Nausea—Simvastatin—coronary artery disease	0.0002	0.00156	CcSEcCtD
Sufentanil—Anaphylactic shock—Lisinopril—coronary artery disease	0.0002	0.00156	CcSEcCtD
Sufentanil—Pruritus—Captopril—coronary artery disease	0.0002	0.00156	CcSEcCtD
Sufentanil—Rash—Olmesartan—coronary artery disease	0.0002	0.00156	CcSEcCtD
Sufentanil—Dermatitis—Olmesartan—coronary artery disease	0.0002	0.00156	CcSEcCtD
Sufentanil—Headache—Valsartan—coronary artery disease	0.000199	0.00156	CcSEcCtD
Sufentanil—Headache—Olmesartan—coronary artery disease	0.000198	0.00155	CcSEcCtD
Sufentanil—Vomiting—Niacin—coronary artery disease	0.000197	0.00154	CcSEcCtD
Sufentanil—Hypersensitivity—Furosemide—coronary artery disease	0.000197	0.00153	CcSEcCtD
Sufentanil—Somnolence—Ramipril—coronary artery disease	0.000196	0.00153	CcSEcCtD
Sufentanil—Dizziness—Trandolapril—coronary artery disease	0.000196	0.00153	CcSEcCtD
Sufentanil—Tachycardia—Lisinopril—coronary artery disease	0.000195	0.00153	CcSEcCtD
Sufentanil—Rash—Niacin—coronary artery disease	0.000195	0.00152	CcSEcCtD
Sufentanil—Dermatitis—Niacin—coronary artery disease	0.000195	0.00152	CcSEcCtD
Sufentanil—Dizziness—Enalapril—coronary artery disease	0.000195	0.00152	CcSEcCtD
Sufentanil—Pruritus—Perindopril—coronary artery disease	0.000194	0.00152	CcSEcCtD
Sufentanil—Headache—Niacin—coronary artery disease	0.000194	0.00151	CcSEcCtD
Sufentanil—Vomiting—Pravastatin—coronary artery disease	0.000194	0.00151	CcSEcCtD
Sufentanil—Dizziness—Telmisartan—coronary artery disease	0.000192	0.0015	CcSEcCtD
Sufentanil—Rash—Pravastatin—coronary artery disease	0.000192	0.0015	CcSEcCtD
Sufentanil—Dermatitis—Pravastatin—coronary artery disease	0.000192	0.0015	CcSEcCtD
Sufentanil—Somnolence—Timolol—coronary artery disease	0.000192	0.0015	CcSEcCtD
Sufentanil—Headache—Pravastatin—coronary artery disease	0.000191	0.00149	CcSEcCtD
Sufentanil—Hypersensitivity—Losartan—coronary artery disease	0.00019	0.00148	CcSEcCtD
Sufentanil—Nausea—Valsartan—coronary artery disease	0.000189	0.00148	CcSEcCtD
Sufentanil—Pruritus—Furosemide—coronary artery disease	0.000189	0.00147	CcSEcCtD
Sufentanil—Nausea—Olmesartan—coronary artery disease	0.000188	0.00147	CcSEcCtD
Sufentanil—Vomiting—Trandolapril—coronary artery disease	0.000188	0.00147	CcSEcCtD
Sufentanil—Vomiting—Enalapril—coronary artery disease	0.000187	0.00146	CcSEcCtD
Sufentanil—Hypotension—Lisinopril—coronary artery disease	0.000187	0.00146	CcSEcCtD
Sufentanil—Dizziness—Captopril—coronary artery disease	0.000187	0.00146	CcSEcCtD
Sufentanil—Rash—Trandolapril—coronary artery disease	0.000187	0.00146	CcSEcCtD
Sufentanil—Dermatitis—Trandolapril—coronary artery disease	0.000186	0.00146	CcSEcCtD
Sufentanil—Rash—Enalapril—coronary artery disease	0.000186	0.00145	CcSEcCtD
Sufentanil—Dermatitis—Enalapril—coronary artery disease	0.000186	0.00145	CcSEcCtD
Sufentanil—Headache—Trandolapril—coronary artery disease	0.000185	0.00145	CcSEcCtD
Sufentanil—Vomiting—Telmisartan—coronary artery disease	0.000185	0.00144	CcSEcCtD
Sufentanil—Headache—Enalapril—coronary artery disease	0.000185	0.00144	CcSEcCtD
Sufentanil—Nausea—Niacin—coronary artery disease	0.000184	0.00144	CcSEcCtD
Sufentanil—Rash—Telmisartan—coronary artery disease	0.000183	0.00143	CcSEcCtD
Sufentanil—Dermatitis—Telmisartan—coronary artery disease	0.000183	0.00143	CcSEcCtD
Sufentanil—Pruritus—Losartan—coronary artery disease	0.000182	0.00142	CcSEcCtD
Sufentanil—Headache—Telmisartan—coronary artery disease	0.000182	0.00142	CcSEcCtD
Sufentanil—Feeling abnormal—Ramipril—coronary artery disease	0.000182	0.00142	CcSEcCtD
Sufentanil—Dizziness—Perindopril—coronary artery disease	0.000182	0.00142	CcSEcCtD
Sufentanil—Nausea—Pravastatin—coronary artery disease	0.000181	0.00141	CcSEcCtD
Sufentanil—Vomiting—Captopril—coronary artery disease	0.00018	0.0014	CcSEcCtD
Sufentanil—Rash—Captopril—coronary artery disease	0.000178	0.00139	CcSEcCtD
Sufentanil—Dermatitis—Captopril—coronary artery disease	0.000178	0.00139	CcSEcCtD
Sufentanil—Somnolence—Lisinopril—coronary artery disease	0.000178	0.00139	CcSEcCtD
Sufentanil—Feeling abnormal—Timolol—coronary artery disease	0.000178	0.00139	CcSEcCtD
Sufentanil—Headache—Captopril—coronary artery disease	0.000177	0.00138	CcSEcCtD
Sufentanil—Dizziness—Furosemide—coronary artery disease	0.000176	0.00138	CcSEcCtD
Sufentanil—Nausea—Trandolapril—coronary artery disease	0.000176	0.00137	CcSEcCtD
Sufentanil—Nausea—Enalapril—coronary artery disease	0.000175	0.00137	CcSEcCtD
Sufentanil—Vomiting—Perindopril—coronary artery disease	0.000175	0.00136	CcSEcCtD
Sufentanil—Body temperature increased—Ramipril—coronary artery disease	0.000175	0.00136	CcSEcCtD
Sufentanil—Rash—Perindopril—coronary artery disease	0.000173	0.00135	CcSEcCtD
Sufentanil—Dermatitis—Perindopril—coronary artery disease	0.000173	0.00135	CcSEcCtD
Sufentanil—Nausea—Telmisartan—coronary artery disease	0.000173	0.00135	CcSEcCtD
Sufentanil—Headache—Perindopril—coronary artery disease	0.000172	0.00134	CcSEcCtD
Sufentanil—Body temperature increased—Timolol—coronary artery disease	0.000171	0.00133	CcSEcCtD
Sufentanil—Dizziness—Losartan—coronary artery disease	0.00017	0.00133	CcSEcCtD
Sufentanil—Vomiting—Furosemide—coronary artery disease	0.00017	0.00132	CcSEcCtD
Sufentanil—Rash—Furosemide—coronary artery disease	0.000168	0.00131	CcSEcCtD
Sufentanil—Dermatitis—Furosemide—coronary artery disease	0.000168	0.00131	CcSEcCtD
Sufentanil—Nausea—Captopril—coronary artery disease	0.000168	0.00131	CcSEcCtD
Sufentanil—Headache—Furosemide—coronary artery disease	0.000167	0.00131	CcSEcCtD
Sufentanil—Feeling abnormal—Lisinopril—coronary artery disease	0.000165	0.00129	CcSEcCtD
Sufentanil—Vomiting—Losartan—coronary artery disease	0.000164	0.00128	CcSEcCtD
Sufentanil—Nausea—Perindopril—coronary artery disease	0.000163	0.00127	CcSEcCtD
Sufentanil—Hypersensitivity—Ramipril—coronary artery disease	0.000163	0.00127	CcSEcCtD
Sufentanil—Rash—Losartan—coronary artery disease	0.000162	0.00127	CcSEcCtD
Sufentanil—Dermatitis—Losartan—coronary artery disease	0.000162	0.00127	CcSEcCtD
Sufentanil—Headache—Losartan—coronary artery disease	0.000161	0.00126	CcSEcCtD
Sufentanil—Hypersensitivity—Timolol—coronary artery disease	0.000159	0.00124	CcSEcCtD
Sufentanil—Nausea—Furosemide—coronary artery disease	0.000158	0.00124	CcSEcCtD
Sufentanil—Body temperature increased—Lisinopril—coronary artery disease	0.000158	0.00124	CcSEcCtD
Sufentanil—Pruritus—Ramipril—coronary artery disease	0.000156	0.00122	CcSEcCtD
Sufentanil—Nausea—Losartan—coronary artery disease	0.000153	0.00119	CcSEcCtD
Sufentanil—Pruritus—Timolol—coronary artery disease	0.000153	0.00119	CcSEcCtD
Sufentanil—Hypersensitivity—Lisinopril—coronary artery disease	0.000148	0.00115	CcSEcCtD
Sufentanil—Dizziness—Ramipril—coronary artery disease	0.000146	0.00114	CcSEcCtD
Sufentanil—Dizziness—Timolol—coronary artery disease	0.000143	0.00111	CcSEcCtD
Sufentanil—Pruritus—Lisinopril—coronary artery disease	0.000142	0.00111	CcSEcCtD
Sufentanil—Vomiting—Ramipril—coronary artery disease	0.00014	0.0011	CcSEcCtD
Sufentanil—Rash—Ramipril—coronary artery disease	0.000139	0.00109	CcSEcCtD
Sufentanil—Dermatitis—Ramipril—coronary artery disease	0.000139	0.00109	CcSEcCtD
Sufentanil—Headache—Ramipril—coronary artery disease	0.000138	0.00108	CcSEcCtD
Sufentanil—Vomiting—Timolol—coronary artery disease	0.000137	0.00107	CcSEcCtD
Sufentanil—Rash—Timolol—coronary artery disease	0.000136	0.00106	CcSEcCtD
Sufentanil—Dermatitis—Timolol—coronary artery disease	0.000136	0.00106	CcSEcCtD
Sufentanil—Headache—Timolol—coronary artery disease	0.000135	0.00106	CcSEcCtD
Sufentanil—Dizziness—Lisinopril—coronary artery disease	0.000132	0.00103	CcSEcCtD
Sufentanil—Nausea—Ramipril—coronary artery disease	0.000131	0.00102	CcSEcCtD
Sufentanil—Nausea—Timolol—coronary artery disease	0.000128	0.001	CcSEcCtD
Sufentanil—Vomiting—Lisinopril—coronary artery disease	0.000127	0.000994	CcSEcCtD
Sufentanil—Rash—Lisinopril—coronary artery disease	0.000126	0.000986	CcSEcCtD
Sufentanil—Dermatitis—Lisinopril—coronary artery disease	0.000126	0.000985	CcSEcCtD
Sufentanil—Headache—Lisinopril—coronary artery disease	0.000125	0.000979	CcSEcCtD
Sufentanil—Nausea—Lisinopril—coronary artery disease	0.000119	0.000928	CcSEcCtD
Sufentanil—OPRK1—Signaling Pathways—EDN1—coronary artery disease	1.2e-05	0.000131	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—POMC—coronary artery disease	1.2e-05	0.00013	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—CREB1—coronary artery disease	1.2e-05	0.00013	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—HTR2A—coronary artery disease	1.2e-05	0.00013	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—AGTR1—coronary artery disease	1.2e-05	0.00013	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—C3—coronary artery disease	1.2e-05	0.00013	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—CCL5—coronary artery disease	1.19e-05	0.00013	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—CCL2—coronary artery disease	1.17e-05	0.000128	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—FGF1—coronary artery disease	1.17e-05	0.000128	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—CSF2—coronary artery disease	1.17e-05	0.000128	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—UGCG—coronary artery disease	1.17e-05	0.000127	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—MDH2—coronary artery disease	1.17e-05	0.000127	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—PPAT—coronary artery disease	1.17e-05	0.000127	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—PLCD1—coronary artery disease	1.17e-05	0.000127	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—IL6R—coronary artery disease	1.17e-05	0.000127	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—CXCL10—coronary artery disease	1.17e-05	0.000127	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—PLG—coronary artery disease	1.17e-05	0.000127	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—LPL—coronary artery disease	1.17e-05	0.000127	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—MEF2C—coronary artery disease	1.15e-05	0.000126	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—RPS6KB1—coronary artery disease	1.15e-05	0.000126	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—HIF1A—coronary artery disease	1.14e-05	0.000124	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—AGT—coronary artery disease	1.14e-05	0.000124	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—ADRB2—coronary artery disease	1.14e-05	0.000123	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—PGM1—coronary artery disease	1.13e-05	0.000123	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—ITGB3—coronary artery disease	1.13e-05	0.000122	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—PRKCE—coronary artery disease	1.12e-05	0.000122	CbGpPWpGaD
Sufentanil—OPRM1—GPCR downstream signaling—JAK2—coronary artery disease	1.12e-05	0.000122	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—SOCS1—coronary artery disease	1.12e-05	0.000122	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—S100B—coronary artery disease	1.12e-05	0.000121	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—APOE—coronary artery disease	1.11e-05	0.000121	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—LEP—coronary artery disease	1.11e-05	0.000121	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—SOCS3—coronary artery disease	1.1e-05	0.00012	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—APOA1—coronary artery disease	1.1e-05	0.00012	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—CXCL8—coronary artery disease	1.1e-05	0.000119	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—PPP2CA—coronary artery disease	1.09e-05	0.000119	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—KITLG—coronary artery disease	1.09e-05	0.000119	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—TGFBR2—coronary artery disease	1.09e-05	0.000119	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—KDR—coronary artery disease	1.09e-05	0.000119	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—PYGB—coronary artery disease	1.09e-05	0.000118	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—CKB—coronary artery disease	1.09e-05	0.000118	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—MAPK14—coronary artery disease	1.08e-05	0.000118	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—PRKCD—coronary artery disease	1.07e-05	0.000117	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—MMP3—coronary artery disease	1.07e-05	0.000116	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—STAT5A—coronary artery disease	1.07e-05	0.000116	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—ESR1—coronary artery disease	1.06e-05	0.000116	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—HTR2A—coronary artery disease	1.05e-05	0.000114	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—FN1—coronary artery disease	1.05e-05	0.000114	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—F2—coronary artery disease	1.05e-05	0.000114	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—C3—coronary artery disease	1.05e-05	0.000114	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—IL6ST—coronary artery disease	1.05e-05	0.000114	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—NFKBIA—coronary artery disease	1.04e-05	0.000113	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—APOB—coronary artery disease	1.03e-05	0.000112	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—COX5B—coronary artery disease	1.02e-05	0.000111	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—PLIN1—coronary artery disease	1.02e-05	0.000111	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—PFKFB3—coronary artery disease	1.02e-05	0.000111	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—DLAT—coronary artery disease	1.02e-05	0.000111	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—GSTM2—coronary artery disease	1.02e-05	0.000111	CbGpPWpGaD
Sufentanil—OPRM1—GPCR downstream signaling—CXCL8—coronary artery disease	1.02e-05	0.000111	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—JAK2—coronary artery disease	1.02e-05	0.000111	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—EDN1—coronary artery disease	1.01e-05	0.00011	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—CCL5—coronary artery disease	1.01e-05	0.000109	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—KIT—coronary artery disease	1.01e-05	0.000109	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—HIF1A—coronary artery disease	1e-05	0.000109	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—AGT—coronary artery disease	9.97e-06	0.000108	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—CSF2—coronary artery disease	9.92e-06	0.000108	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—FGF1—coronary artery disease	9.92e-06	0.000108	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—LPL—coronary artery disease	9.85e-06	0.000107	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—APOE—coronary artery disease	9.77e-06	0.000106	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—LEP—coronary artery disease	9.77e-06	0.000106	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—RPS6KB1—coronary artery disease	9.76e-06	0.000106	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—MEF2C—coronary artery disease	9.76e-06	0.000106	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—SULT1E1—coronary artery disease	9.71e-06	0.000106	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—APOA1—coronary artery disease	9.65e-06	0.000105	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—GSK3B—coronary artery disease	9.65e-06	0.000105	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—KDR—coronary artery disease	9.57e-06	0.000104	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—POMC—coronary artery disease	9.57e-06	0.000104	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—CREB1—coronary artery disease	9.57e-06	0.000104	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—ITGB3—coronary artery disease	9.51e-06	0.000103	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—MAPK14—coronary artery disease	9.51e-06	0.000103	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—CCL2—coronary artery disease	9.36e-06	0.000102	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—IL6R—coronary artery disease	9.33e-06	0.000101	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—ESR1—coronary artery disease	9.32e-06	0.000101	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—CXCL8—coronary artery disease	9.29e-06	0.000101	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—AKR1B1—coronary artery disease	9.26e-06	0.000101	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—HK2—coronary artery disease	9.26e-06	0.000101	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—PPP2CA—coronary artery disease	9.24e-06	0.0001	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—FN1—coronary artery disease	9.21e-06	0.0001	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—F2—coronary artery disease	9.21e-06	0.0001	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—IGF1—coronary artery disease	9.2e-06	0.0001	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—IL6ST—coronary artery disease	9.17e-06	9.97e-05	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—MAPK1—coronary artery disease	9.16e-06	9.96e-05	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—NFKBIA—coronary artery disease	9.1e-06	9.89e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—PRKCD—coronary artery disease	9.07e-06	9.86e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—SLC27A1—coronary artery disease	8.88e-06	9.66e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—HTR2A—coronary artery disease	8.88e-06	9.65e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—C3—coronary artery disease	8.87e-06	9.64e-05	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—KIT—coronary artery disease	8.81e-06	9.58e-05	CbGpPWpGaD
Sufentanil—OPRD1—GPCR downstream signaling—PIK3CA—coronary artery disease	8.75e-06	9.51e-05	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—SERPINE1—coronary artery disease	8.74e-06	9.5e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—CPT1B—coronary artery disease	8.71e-06	9.47e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—LCAT—coronary artery disease	8.71e-06	9.47e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—APOA4—coronary artery disease	8.55e-06	9.29e-05	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—FGF2—coronary artery disease	8.46e-06	9.2e-05	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—GSK3B—coronary artery disease	8.46e-06	9.19e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—HIF1A—coronary artery disease	8.46e-06	9.19e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—AGT—coronary artery disease	8.42e-06	9.16e-05	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—POMC—coronary artery disease	8.39e-06	9.12e-05	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—CREB1—coronary artery disease	8.39e-06	9.12e-05	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—NOS3—coronary artery disease	8.34e-06	9.07e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—PDHA1—coronary artery disease	8.26e-06	8.98e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—GCLM—coronary artery disease	8.26e-06	8.98e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—APOE—coronary artery disease	8.25e-06	8.97e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—LEP—coronary artery disease	8.25e-06	8.97e-05	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—CCL2—coronary artery disease	8.21e-06	8.92e-05	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—IL6R—coronary artery disease	8.18e-06	8.9e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—APOA1—coronary artery disease	8.16e-06	8.87e-05	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—JAK2—coronary artery disease	8.11e-06	8.82e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—KDR—coronary artery disease	8.09e-06	8.79e-05	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—IGF1—coronary artery disease	8.07e-06	8.77e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—MAPK14—coronary artery disease	8.03e-06	8.73e-05	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—MAPK1—coronary artery disease	8.03e-06	8.73e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—CYP11B2—coronary artery disease	8e-06	8.69e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—TXNRD1—coronary artery disease	8e-06	8.69e-05	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—PIK3CA—coronary artery disease	7.95e-06	8.64e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—ESR1—coronary artery disease	7.88e-06	8.57e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—SLC22A3—coronary artery disease	7.88e-06	8.56e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—FN1—coronary artery disease	7.78e-06	8.46e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—F2—coronary artery disease	7.78e-06	8.46e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—HADH—coronary artery disease	7.76e-06	8.44e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—ARNTL—coronary artery disease	7.76e-06	8.44e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—IL6ST—coronary artery disease	7.75e-06	8.43e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—NFKBIA—coronary artery disease	7.69e-06	8.36e-05	CbGpPWpGaD
Sufentanil—OPRK1—GPCR downstream signaling—PIK3CA—coronary artery disease	7.68e-06	8.34e-05	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—SERPINE1—coronary artery disease	7.66e-06	8.33e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—KIT—coronary artery disease	7.45e-06	8.1e-05	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—FGF2—coronary artery disease	7.42e-06	8.06e-05	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—CXCL8—coronary artery disease	7.4e-06	8.05e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—APOA2—coronary artery disease	7.36e-06	8e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—PLA2G2A—coronary artery disease	7.36e-06	8e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—GPX2—coronary artery disease	7.36e-06	8e-05	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—NOS3—coronary artery disease	7.32e-06	7.95e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—SULT1A1—coronary artery disease	7.27e-06	7.9e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—ABCG5—coronary artery disease	7.27e-06	7.9e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—GPX4—coronary artery disease	7.27e-06	7.9e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—HK1—coronary artery disease	7.27e-06	7.9e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—HADHA—coronary artery disease	7.18e-06	7.81e-05	CbGpPWpGaD
Sufentanil—OPRD1—GPCR downstream signaling—AKT1—coronary artery disease	7.15e-06	7.77e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—GSK3B—coronary artery disease	7.15e-06	7.77e-05	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—JAK2—coronary artery disease	7.11e-06	7.73e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—GSTA1—coronary artery disease	7.1e-06	7.72e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—CREB1—coronary artery disease	7.09e-06	7.71e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—POMC—coronary artery disease	7.09e-06	7.71e-05	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—CASP3—coronary artery disease	7.08e-06	7.7e-05	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—IL6—coronary artery disease	7.04e-06	7.65e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—LPA—coronary artery disease	7.02e-06	7.63e-05	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—PIK3CA—coronary artery disease	6.97e-06	7.58e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—CCL2—coronary artery disease	6.94e-06	7.54e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—IL6R—coronary artery disease	6.92e-06	7.52e-05	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—CCND1—coronary artery disease	6.9e-06	7.5e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—IGF1—coronary artery disease	6.82e-06	7.41e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—PLCB3—coronary artery disease	6.8e-06	7.39e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—MAPK1—coronary artery disease	6.79e-06	7.38e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—APOA5—coronary artery disease	6.73e-06	7.32e-05	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—MMP9—coronary artery disease	6.69e-06	7.28e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—P4HB—coronary artery disease	6.6e-06	7.18e-05	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—AKT1—coronary artery disease	6.49e-06	7.06e-05	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—CXCL8—coronary artery disease	6.49e-06	7.06e-05	CbGpPWpGaD
Sufentanil—OPRM1—GPCR downstream signaling—PIK3CA—coronary artery disease	6.49e-06	7.05e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—PLA2G1B—coronary artery disease	6.48e-06	7.04e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—SERPINE1—coronary artery disease	6.48e-06	7.04e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—FGF2—coronary artery disease	6.27e-06	6.82e-05	CbGpPWpGaD
Sufentanil—OPRK1—GPCR downstream signaling—AKT1—coronary artery disease	6.27e-06	6.82e-05	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—CASP3—coronary artery disease	6.21e-06	6.75e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—NOS3—coronary artery disease	6.18e-06	6.72e-05	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—IL6—coronary artery disease	6.17e-06	6.71e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—VCAN—coronary artery disease	6.11e-06	6.64e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—ALDOA—coronary artery disease	6.06e-06	6.59e-05	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—CCND1—coronary artery disease	6.05e-06	6.57e-05	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—VEGFA—coronary artery disease	6.01e-06	6.53e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—JAK2—coronary artery disease	6.01e-06	6.53e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—PIK3CA—coronary artery disease	5.89e-06	6.4e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—DCN—coronary artery disease	5.88e-06	6.4e-05	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—MMP9—coronary artery disease	5.87e-06	6.38e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—ALDH2—coronary artery disease	5.72e-06	6.22e-05	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—AKT1—coronary artery disease	5.69e-06	6.19e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—LIPC—coronary artery disease	5.58e-06	6.06e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—CYP2C19—coronary artery disease	5.58e-06	6.06e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—PIK3C2A—coronary artery disease	5.58e-06	6.06e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—HBA1—coronary artery disease	5.58e-06	6.06e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—APOC3—coronary artery disease	5.54e-06	6.03e-05	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—TGFB1—coronary artery disease	5.52e-06	6e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—LDLR—coronary artery disease	5.51e-06	5.99e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—CXCL8—coronary artery disease	5.49e-06	5.96e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—SLC9A1—coronary artery disease	5.44e-06	5.92e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—GSTT1—coronary artery disease	5.44e-06	5.92e-05	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—MAPK1—coronary artery disease	5.41e-06	5.88e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—CETP—coronary artery disease	5.38e-06	5.85e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—GCLC—coronary artery disease	5.38e-06	5.85e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—SDC1—coronary artery disease	5.32e-06	5.78e-05	CbGpPWpGaD
Sufentanil—OPRM1—GPCR downstream signaling—AKT1—coronary artery disease	5.3e-06	5.76e-05	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—VEGFA—coronary artery disease	5.27e-06	5.73e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—CASP3—coronary artery disease	5.25e-06	5.71e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—IL6—coronary artery disease	5.22e-06	5.67e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—CCND1—coronary artery disease	5.11e-06	5.56e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—PSMA6—coronary artery disease	5.03e-06	5.46e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—PSMB5—coronary artery disease	5.03e-06	5.46e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—MMP9—coronary artery disease	4.96e-06	5.39e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—CTGF—coronary artery disease	4.91e-06	5.34e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—GOT2—coronary artery disease	4.87e-06	5.29e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—HMGCR—coronary artery disease	4.87e-06	5.29e-05	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—TGFB1—coronary artery disease	4.84e-06	5.26e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—AKT1—coronary artery disease	4.81e-06	5.23e-05	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—MAPK1—coronary artery disease	4.74e-06	5.16e-05	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—PIK3CA—coronary artery disease	4.7e-06	5.1e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—PLCB1—coronary artery disease	4.48e-06	4.86e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—VEGFA—coronary artery disease	4.46e-06	4.84e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—ABCA1—coronary artery disease	4.34e-06	4.72e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—GOT1—coronary artery disease	4.2e-06	4.57e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—GGT1—coronary artery disease	4.2e-06	4.57e-05	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—IL6—coronary artery disease	4.16e-06	4.52e-05	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—PIK3CA—coronary artery disease	4.12e-06	4.48e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—TGFB1—coronary artery disease	4.09e-06	4.45e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—MAPK1—coronary artery disease	4.01e-06	4.36e-05	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—AKT1—coronary artery disease	3.84e-06	4.17e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—GSTP1—coronary artery disease	3.77e-06	4.1e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—PPARGC1A—coronary artery disease	3.74e-06	4.06e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—HMOX1—coronary artery disease	3.72e-06	4.05e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—CAT—coronary artery disease	3.67e-06	3.99e-05	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—IL6—coronary artery disease	3.65e-06	3.96e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—APOB—coronary artery disease	3.56e-06	3.88e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—PIK3CA—coronary artery disease	3.48e-06	3.78e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—GSTM1—coronary artery disease	3.47e-06	3.77e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—LPL—coronary artery disease	3.4e-06	3.7e-05	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—AKT1—coronary artery disease	3.36e-06	3.66e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—GPX1—coronary artery disease	3.32e-06	3.61e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—CD36—coronary artery disease	3.23e-06	3.52e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—PPP2CA—coronary artery disease	3.19e-06	3.47e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—IL6—coronary artery disease	3.08e-06	3.35e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—MTHFR—coronary artery disease	3.06e-06	3.33e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—AGT—coronary artery disease	2.91e-06	3.17e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—APOE—coronary artery disease	2.85e-06	3.1e-05	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—AKT1—coronary artery disease	2.84e-06	3.09e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—APOA1—coronary artery disease	2.82e-06	3.07e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—PPARG—coronary artery disease	2.49e-06	2.7e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—POMC—coronary artery disease	2.45e-06	2.66e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—ALB—coronary artery disease	2.23e-06	2.43e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—NOS3—coronary artery disease	2.14e-06	2.32e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—PTGS2—coronary artery disease	1.96e-06	2.13e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—PIK3CA—coronary artery disease	1.2e-06	1.31e-05	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—AKT1—coronary artery disease	9.83e-07	1.07e-05	CbGpPWpGaD
